UC Berkeley Public Health research suggest SSRIs, which increase serotonin availability, may reduce the risk of long COVID by 8%, potentially due to their impact on serotonin production affected by SARS-CoV-2 in the gut. The study, led by postdoctoral scholar Zachary Butzin-Dozier, analyzed health records of 300,000 patients and found possible links between SSRIs and symptom reduction. Read more: https://ow.ly/7mZT50UnR5Q #LongCOVID #SSRIs #Biostatistics #UCBerkeley #BerkeleyPublicHealth #PublicHealth #COVID